2024. Deucravacitinib Long-Term Efficacy in Week 16 Placebo Crossovers: 3-year Results from the POETYK PSO Program. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s365. DOI:https://doi.org/10.25251/skin.8.supp.365.